Loading...
Market
Will the DEA establish new telehealth prescribing rules by March 2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
DEA official publications or announcements in major news outlets
Story
Telehealth Providers Urge DEA to Extend Pandemic Waiver for Prescribing Controlled Substances
Oct 10, 2024, 01:42 PM
Telehealth providers prescribing controlled substances face chaos as pandemic-era flexibilities are set to end in just months, with no new rules in sight. The DEA had granted a 2020 legal waiver allowing telehealth startups to prescribe controlled substances without requiring an in-person doctor visit. With these flexibilities ending, telehealth leaders are pressing the DEA to extend the waiver, blaming the agency for putting their businesses at serious risk. Silicon Valley telehealth startups, launched during the pandemic, are now engaging in policy advocacy for the first time.
View original story
Similar markets
Permanent rule allowing telehealth prescribing • 25%
Temporary extension beyond 2025 • 25%
Reversion to pre-COVID rules • 25%
Other • 25%
Patients • 25%
Telehealth providers • 25%
Pharmaceutical companies • 25%
Other • 25%
Trump Administration • 33%
Next Administration • 33%
No permanent policy by end of 2025 • 34%
Addiction treatment • 25%
ADHD medication • 25%
Opioid prescriptions • 25%
Other controlled substances • 25%
Current administration • 25%
Incoming administration • 25%
Both administrations • 25%
Neither • 25%